Please assess the completion status of the following clinical trial:

Trial Title: A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who have a DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) diagnosis of schizophrenia or schizoaffective disorder~* Taking a stable dose of olanzapine for at least 30 days~* Have not experienced an acute exacerbation of their psychotic symptoms in the preceding 3 months~* Either had only a marginal clinical response to olanzapine, or had unacceptable side effects related to weight gain including obesity, diabetes or abnormal glucose metabolism~Exclusion Criteria:~* Patients with a history of treatment failure with, or significant adverse events attributable to, risperidone, or known sensitivity to risperidone~* A history of antipsychotic therapy other than olanzapine in the 30 days preceding randomization~* Presence of serious or unstable illnesses: liver or renal insufficiency, significant cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurological, psychiatric or metabolic disturbances~* Diagnosis of substance dependence~* Pregnant or nursing female, or those lacking adequate contraception

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).